BioSpace News Archive

Retrophin, Inc. today announced that presentations highlighting the design of the ongoing pivotal Phase 3 FORT Study of fosmetpantotenate for the treatment of pantothenate kinase-associated neurodegeneration (PKAN), the patient and caregiver experience with PKAN, and the diagnostic pathway and clinical experience of patients with PKAN, will be presented by the Company and its collaborators at upcoming medical congresses in October.

RXi Pharmaceuticals Corporation today announced the closing of its previously announced underwritten public offering of 3,725,714 units at a public offering price of $0.70 per unit and 17,702,858 pre-funded units at a public offering price of $0.69 per pre-funded unit, raising gross proceeds of approximately $15 million.

AmerisourceBergen Corporation today announced that it plans to release its results for the Fourth Quarter Fiscal 2018 on Tuesday, November 6, 2018, prior to the opening of trading on the New York Stock Exchange.

Event to be Webcast Live on Thursday, October 11, 2018, at 8:30 a.m. ET

President’s Signature will Make Permanent the Authorization for NPs to Prescribe Medication Assisted Treatments

New studies highlight health and economic benefits of adjuvanted trivalent influenza vaccine amongst two at-risk populations - 65 years+ and young children

AAKP Convenes Capitol Hill Meeting with Broad Range of Key Policy Influencers

Birner Dental Management, Inc. Shareholders to Receive Total Cash Consideration of up to $10.75 per share

ICC Labs Inc. is pleased to announce that it has obtained an interim order of the Supreme Court of British Columbia authorizing, among other things, the holding of the Company’s special meeting of holders (the ICC Shareholders) of common shares (ICC Shares).

Spring Bank Pharmaceuticals, Inc. today announced it will present inarigivir soproxil (inarigivir) data in both an oral and poster presentation at the American Association for the Study of Liver Disease (AASLD) Annual Meeting (The Liver Meeting®) being held on November 9-13 in San Francisco, CA.